Close

Gibril NDOW

Clinical Research Fellow

United Kingdom

Tel.
+2204495442
I am a consultant in Infectious Diseases with a PhD in Clinical Medicine Research. I have more than 10 years' cumulative experience in viral hepatitis research and clinical care in Africa. I currently lead the Hepatitis Research Group at the MRC Unit The Gambia at LSHTM and coordinate the PROLIFICA program in The Gambia (www.prolifica.africa). I am a Board Member of the Society on Liver Disease in Africa (SOLDA) and serve on both the organising and scientific committees of the Conference on Liver Disease in Africa (COLDA).

Affiliations

MRC Unit The Gambia at LSHTM

Research

My research investigates the underlying mechanisms and outcomes of chronic hepatitis B infection in Africans, with an aim to develop new biomarkers to simply diagnosis and monitoring, predict prognosis and identify new targets for curative therapy.
Research Area
Disease control
Clinical guidelines
Epidemiology
Medicine
Disease and Health Conditions
Hepatitis
Cancer
Cirrhosis
Non-communicable diseases
Country
Gambia
Senegal
Burkina Faso
Region
Sub-Saharan Africa (all income levels)

Selected Publications

Hepatitis B discrimination: global responses requiring global data.
Freeland, C; Qureshi, A; Wallace, J; Kabagambe, K; Desalegn, H; Munoz, C; Lee, D; Owusu-Ansah, T; Adda, D; NDOW, G; Yousif, S; Abdalla, H; Kheir, O; Tu, T; Cohen, C;
2024
BMC public health
TREAT-B or Treat All: time for a broader vision on hepatitis B elimination - Author's reply.
Luong Nguyen, LB; Lemoine, M; NDOW, G; Nayagam, S; Shimakawa, Y;
2024
The Lancet. Global health
Direct-acting antiviral therapies for hepatitis C infection: global registration, reimbursement, and restrictions.
Marshall, AD; Willing, AR; Kairouz, A; Cunningham, EB; Wheeler, A; O'Brien, N; Perera, V; Ward, JW; Hiebert, L; Degenhardt, L; Hajarizadeh, B; Colledge, S; Hickman, M; Jawad, D; Lazarus, JV; Matthews, GV; Scheibe, A; Vickerman, P; Dore, GJ; Grebely, J; Global HCV and HIV Treatment Restrictions Group,;
2024
The lancet. Gastroenterology & hepatology
Development and evaluation of a simple treatment eligibility score (HEPSANET) to decentralise hepatitis B care in Africa: a cross-sectional study.
Minier, N; Guingané, AN; Okeke, E; Sinkala, E; Johannessen, A; Andersson, MI; Davwar, P; Desalegn, H; Duguru, M; Fall, F; Mboup, S; Maponga, T; Matthews, PC; Ramírez Mena, A; NDOW, G; Orlien, SM S; Riches, N; Seydi, M; Sonderup, M; Spearman, CW; Stockdale, AJ; Taljaard, J; Vinikoor, M; Wandeler, G; Lemoine, M; ... Sombié, R.
2024
The lancet. Gastroenterology & hepatology
Treat All versus targeted strategies to select HBV-infected people for antiviral therapy in The Gambia, west Africa: a cost-effectiveness analysis.
Nguyen, LB L; Lemoine, M; NDOW, G; Ward, ZJ; Hallet, TB; D'Alessandro, U; Thursz, M; Nayagam, S; Shimakawa, Y;
2024
The Lancet. Global health
Clinical characteristics and outcomes of patients with cirrhosis and hepatocellular carcinoma in The Gambia, west Africa: a prospective cohort study.
NDOW, G; Vo-Quang, E; Shimakawa, Y; Ceesay, A; Tamba, S; Njai, HF; Bojang, L; Hateley, C; Takao, Y; Opoku, E; Warsop, Z; Ingiliz, P; D'ALESSANDRO, U; Chemin, I; Mendy, M; Thursz, M; Njie, R; Lemoine, M;
2023
The Lancet. Global health
Poor disease knowledge among people living with hepatitis B in The Gambia and Tanzania.
Vo-Quang, E; Bangura, R; Adam, N; NDOW, G; Shimakawa, Y; Lemoine, M;
2023
The lancet. Gastroenterology & hepatology
Informing a target product profile for rapid tests to identify HBV-infected pregnant women with high viral loads: a discrete choice experiment with African healthcare workers.
Isa, YS; Sicsic, J; Njuguna, H; Ward, J; Chakroun, M; El-Kassas, M; Ramanampamonjy, R; Chalal, S; Vincent, JP; Andersson, M; Desalegn, H; Fall, F; Johannessen, A; Matthews, PC; NDOW, G; Okeke, E; Riches, N; Seydi, M; Sinkala, E; Spearman, CW; Stockdale, A; Vinikoor, MJ; Wandeler, G; Sombié, R; Lemoine, M; ... Shimakawa, Y.
2023
BMC medicine
Cost-effectiveness of different monitoring strategies in a screening and treatment programme for hepatitis B in The Gambia.
Schmit, N; Nayagam, S; Lemoine, M; NDOW, G; Shimakawa, Y; Thursz, MR; Hallett, TB;
2023
Journal of global health
Mac-2 binding protein glycosylation isomer (M2BPGi) to evaluate liver fibrosis and cancer in HBV-infected patients in West Africa.
Vincent, JP; NDOW, G; Ogawa, S; Ceesay, A; Njie, R; Sanneh, B; Baldeh, I; D'ALESSANDRO, U; Mendy, M; Thursz, M; Chemin, I; Tanaka, Y; Lemoine, M; Shimakawa, Y;
2022
Journal of global health
See more information